Quarterly report pursuant to Section 13 or 15(d)

Organization, Description of Business, Basis of Presentation, Acquisitions and Recent Accounting Pronouncements - Pro Forma (Details)

v3.4.0.3
Organization, Description of Business, Basis of Presentation, Acquisitions and Recent Accounting Pronouncements - Pro Forma (Details) - Response Genetics, Inc.
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2015
USD ($)
$ / shares
Pro Forma Financial Information  
Revenue | $ $ 8,161
Net loss | $ $ (7,919)
Basic net loss per share (usd per share) | $ / shares $ (0.75)
Dilutive net loss per share (usd per share) | $ / shares $ (0.75)